​
Login / Signup
Laura Sourd
ORCID
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 2
Top Topics
Small Molecule
Study Protocol
Lymph Node Metastasis
Protein Kinase
Top Venues
Cancer research
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Arany Soosainathan
,
Marjan Iravani
,
Rania El-Botty
,
John Alexander
,
Laura Sourd
,
Ludivine Morisset
,
Pierre Painsec
,
Rebecca Orha
,
Joanna Nikitorowicz-Buniak
,
Sunil Pancholi
,
Syed Haider
,
Mitchell Dowsett
,
Elisabetta Marangoni
,
Lesley-Ann Martin
,
Clare M Isacke
Targeting transcriptional regulation with a CDK9 inhibitor suppresses growth of endocrine- and palbociclib-resistant ER+ breast cancers.
Cancer research
(2023)
Peng Peng
,
Xiaoyan Qiang
,
Guoyu Li
,
Lin Li
,
Shumao Ni
,
Qi Yu
,
Laura Sourd
,
Elisabetta Marangoni
,
Chao Hu
,
Dong Wang
,
Di Wu
,
Frank Wu
Tinengotinib (TT-00420), a Novel Spectrum-Selective Small Molecule Kinase Inhibitor, Is Highly Active Against Triple Negative Breast Cancer.
Molecular cancer therapeutics
(2022)